In twenty years psilocybin went from laboratory curiosity to publications in NEJM and JAMA. But in May 2026 the largest and best-blinded trial — EPISODE (n=144) — missed its primary endpoint: 17.0% response versus 10.6% on active placebo. Here is what the evidence actually supports, where the methodology strains, and why an endocrinologist looks at the thyroid first in "treatment-resistant" depression.
Read articleA patient has been on antidepressants for five years with no lasting effect — nobody ever checked TPO antibodies. A case-control study found the lifetime odds of depression are 6.6× higher, and generalized anxiety disorder 4.9× higher, in patients with euthyroid Hashimoto's — with completely normal TSH and fT4. I review exactly which mental illnesses are linked to thyroid disease, the mechanism, and when adding T3 works as an antidepressant strategy.
Read articlePharmacy shelves are full of "liver support" supplements with zero controlled trials behind them. Of that entire market, only three substances have randomized placebo-controlled data specifically in fatty liver disease: vitamin E 800 IU/day (PIVENS, biopsy-confirmed improvement), silymarin 2100 mg/day, and N-acetylcysteine 600 mg twice daily. I review the doses, the evidence quality, and who these protocols are not for.
Read articleFibromyalgia has the strongest evidence base of any low-dose naltrexone (LDN) indication. A randomized crossover trial (Younger 2013) showed a 28.8% pain reduction versus 18.0% on placebo at 4.5 mg. I review the microglia mechanism, realistic titration, and the honest limitations of this evidence.
Read articleThe brain gives no pain signal when it is being lost. I break down the psychological markers of cognitive aging — executive dysfunction and subjective complaints that precede memory loss by years — and what is actually proven to help.
Read articleThere are small thyroid cancers that do not need to be operated on immediately. Instead of surgery, the physician offers active surveillance — regular monitoring by ultrasound. This is not a refusal of treatment but a proven strategy with more than 30 years of history. We explain who it is suitable for and why it is safe.
Read articleWhen a clinician orders "just TSH" — they measure pituitary function, not thyroid function. TSH is a late, inertial marker: it reflects chronic imbalance, not acute dysfunction. Estrogens, biotin, non-thyroidal illness, circadian rhythm — all shift the number without changing thyroid status. Here is the full panel and the decision principle.
Read articleT3 is the only thyroid hormone that actually works. And it works not in blood but inside the cell, at the nuclear receptor. Blood is only a transport phase. Some women with normal TSH have cellular hypothyroidism and suffer with full symptoms despite "normal" labs. Here is the biology of T3, T4→T3 conversion, the hidden forms of deficiency, and the full laboratory panel.
Read articleThe patient has been on levothyroxine for five years, TSH is normal — yet hypothyroid symptoms persist. This is not "poor compliance"; it is a systems failure: peripheral T4→T3 conversion, membrane transport, cofactors, cortisol, gut. We break down what general practice misses and what protocol actually works — with PMIDs, doses, and 8-week control markers.
Read articleTSH normal, free T4 normal, and the patient is falling apart with fatigue, cold intolerance, weight gain, and broken sleep. The classic "your labs are fine" trap. In reality, chronic stress shuts the thyroid down at three different levels, and you only see it on a properly built panel: fT3, rT3, salivary cortisol, ferritin, selenium. Here is the mechanism, the exact numbers, and an 8-week recovery protocol.
Read articleTwo to six weeks after an acute viral infection, the patient returns with "I am not myself" complaints: palpitations, sweating, anxiety — or the opposite, fatigue, edema, apathy. The post-viral thyroid can follow one of three clinically distinct paths. Treatment for each is different. Blanket therapy makes things worse. This review covers how to tell the scenarios apart, what to measure, and when not to prescribe levothyroxine.
Read articleAnti-TPO antibodies are the key to diagnosing autoimmune thyroiditis — but not a treatment target and not a reason for repeat testing. Here is when the test changes management, how to read the titer (35 / 100 / 1000 IU/mL), why an isolated positive without ultrasound and clinical signs is a lab finding rather than Hashimoto, and where selenium actually reduces antibody levels by 30–40%.
Read articleHashimoto's thyroiditis is not a snapshot diagnosis — it is a slow autoimmune process that unfolds over 10–30 years through four sequential stages. Understanding the stage changes clinical strategy: starting levothyroxine in stage 1 is blind therapy; withholding it in stage 3 is malpractice. This article maps the four stages with markers, timing, and the protocol grounded in ATA Guideline.
Read articleUp to 50% of adults have thyroid nodules on ultrasound. The vast majority are benign. The decision to biopsy is not made on the fact of detection but on the TIRADS category combined with size. This review covers the practical ACR TIRADS scale, size thresholds for biopsy, the surveillance protocol, and where Bethesda fits after FNA.
Read articleSelenium is the obligate cofactor of deiodinases and glutathione peroxidases, and the thyroid gland concentrates it more densely than any other organ per gram of tissue. In Hashimoto's thyroiditis, 200 mcg for 6 months reduces TPO antibodies by 30–40%. Less is sub-optimal, more is selenosis. This is the analysis: why exactly this dose, which form works, when selenium is useless, and how to monitor therapy.
Read articleWhat is "normal" for a non-pregnant woman can be hypothyroidism for the fetus. Until weeks 18–20, the fetal CNS develops entirely on maternal thyroid hormones. Here are trimester-specific TSH targets, tactics for anti-TPO positive women, levothyroxine dosing, and iodine prophylaxis per ATA 2017 (PMID 28056690).
Read articleVitamin D raises calcium absorption but does not decide where that calcium goes. Vitamin K2 (menaquinone MK-7) does: into bone via osteocalcin activation, or into arterial walls when deficient. In Hashimoto autoimmune thyroiditis this pair is critical — hypothyroidism itself increases the risk of osteoporosis and vascular calcification. Exact doses, 25(OH)D targets, monitoring, contraindications, and the protocol with levothyroxine.
Read articleAfter thyroid removal, 10–15% of patients on adequate L-thyroxine and "normal" TSH continue to report fatigue, weight gain, cognitive issues. This is not "all in your head" — it is incomplete T4-to-T3 conversion. I break down the US protocol for NDT: composition, brands (Armour, NP Thyroid, ADTHYZA), starting doses, titration, and when L-thyroxine remains the correct choice.
Read articleTSH is "in range" and the patient still has no energy. Up to one in three patients on adequate levothyroxine continues to report residual symptoms. Fatigue runs along three independent axes — T4→T3 conversion, cofactor status (Fe, D3, Mg), and HPA cortisol. Thyroxine closes only one of them. This review covers what to measure beyond TSH and how to start targeted correction based on the result.
Read articleBlack cumin is an ancient spice with 82 RCTs and a GRADE-A meta-analysis on cardiometabolic endpoints today. The active molecule is thymoquinone (TQ). This review covers the five systems where the Nigella sativa effect is clinically proven: vessels and metabolism, the thyroid in Hashimoto, the ovary in PMOS, antioxidant defense, and immunomodulation. With exact numbers, doses, and a treatment protocol.
Read articlePeter Attia, a physician and longevity researcher, reframes what "treating" means in his book "Outlive" (2023). Three key ideas: shifting the point of intervention 20–30 years earlier (Medicine 3.0), the Centenarian Decathlon as a concrete functional target, and the emotional foundation as a biological substrate for every protocol.
Read articleSara Gottfried, a Harvard-trained gynaecologist, formulates three theses in "The Hormone Cure" (2013) that have reshaped integrative gynaeco-endocrinology: cortisol is the "first domino" in hormonal imbalance; standard thyroid testing by TSH alone misses the majority of symptomatic patients; and estrogen dominance is best understood as a ratio with progesterone rather than an absolute estradiol level.
Read articleMatthew Walker, a neuroscientist at UC Berkeley, formulates three ideas in "Why We Sleep" (2017): the four phases of sleep perform distinct biological functions, and shortening sleep to 5–6 hours preferentially deletes REM; sleep debt is a clinically relevant risk factor comparable to smoking; sleep quality depends not only on duration but on alignment with the circadian rhythm.
Read articleTerry Wahls, a professor at the University of Iowa diagnosed with secondary progressive MS who returned from a wheelchair to normal mobility, formulates three theses in "The Wahls Protocol" (2014): mitochondrial dysfunction is the common denominator of chronic disease; "cellular nutrition" through a nutrient-dense plant-rich diet cannot be achieved by supplementation; autoimmune processes are a spectrum, not separate diagnoses.
Read articleDavid Perlmutter, a neurologist in Naples (Florida), formulates three theses in "Grain Brain" (2013): hyperglycaemia is the principal modifiable risk factor for neurodegeneration (Alzheimer's as type 3 diabetes); gluten is a neuroinflammatory trigger even in patients without coeliac disease; ketone bodies are an alternative energy substrate for a brain with impaired glucose utilisation.
Read articleRobert Lustig, a paediatric endocrinologist at UCSF and a prominent anti-sugar advocate, formulates three theses in "The Hacking of the American Mind" (2017): pleasure (dopamine) and happiness (serotonin) are distinct neurochemical systems with opposing regulatory mechanisms; industry has deliberately engineered products, media and interfaces for dopaminergic exploitation; recovery is possible through the four C's — Connect, Contribute, Cope, Cook.
Read articleMichael Pollan, a journalist and food anthropologist, formulates three theses in "In Defense of Food" (2008): nutritionism as a reduction of food to isolated nutrients is a methodological failure; the food matrix has emergent properties not reducible to its components; Western diet syndrome is the common denominator of the epidemic of chronic disease, regardless of the original traditional diet.
Read articleRobert Sapolsky, a Stanford neuroendocrinologist and one of the world's leading stress experts, formulates three theses in "Why Zebras Don't Get Ulcers" (2004): the stress response is evolutionarily designed for acute physical threats, not for chronic abstract ones; social hierarchy is a biological stressor (the Whitehall studies); predictability and control modulate stress damage more than its intensity does.
Read articleBessel van der Kolk, a psychiatrist at Boston University and a leading global expert on psychological trauma, formulates three theses in "The Body Keeps the Score" (2014): trauma is stored in the body as automatic somatic patterns, not only as declarative memory; chronic trauma produces measurable neuroendocrine changes with long-term metabolic and immune consequences; treatment of severe trauma requires bottom-up (somatic) approaches, not only talk therapy.
Read articleJohn Ratey, clinical professor of psychiatry at Harvard Medical School, formulates three theses in "Spark" (2008): physical activity is one of the most powerful antidepressants, anxiolytics and nootropics, comparable in effect to pharmacotherapy; BDNF and related growth factors are the biological mechanism of this effect; cardio before a cognitive task radically improves learning (the Naperville case study).
Read articleThe endothelium is not a passive lining of the vessel but the body’s largest endocrine organ: 1.5 kg, 4,000 m², an area larger than a football field. Its dysfunction precedes visually detectable plaque by 10–20 years. This is a unique therapeutic window in which reversibility has been demonstrated in peer-reviewed data. I review the mechanisms of injury, early markers, and a protocol for restoring the NO factory.
Read articleTrans fats are the only dietary nutrient for which the WHO officially recommends zero. Every additional 2% of energy from trans fats increases the risk of coronary heart disease by 23%. They simultaneously raise LDL and lower HDL, incorporate into cell-membrane phospholipids, reduce membrane flexibility, and activate systemic inflammation. I review the mechanisms of injury, hidden sources, and a protocol for complete elimination.
Read articleThe standard lipid panel (total cholesterol, LDL-C, HDL-C, triglycerides) was developed 60 years ago for screening large populations. It misses 30–40% of patients with already developing atherosclerosis: their numbers remain “normal” until the first myocardial infarction. Modern markers — Lp(a), apoB, hsCRP, CAC-score, oxLDL, and the apoB/apoA1 ratio — detect risk 10–15 years before clinical events. This is the prevention window in which reversibility is evidence-based.
Read articleCholesterol is not a pollutant, but a structural material of every cell membrane and a precursor of steroid hormones. LDL in a clean environment does not initiate atherogenesis. The culprit is not the marker, but the context: oxidation, inflammation, glycation, and small dense subfractions. I explain why total cholesterol is misleading and which tests truly reflect vascular risk.
Read articleMyocardial perfusion scintigraphy remained the workhorse of cardiology for decades. The cost is a radiation dose of 12 mSv per examination, equivalent to 600 chest X-rays. By 2026, CAC-score, stress echocardiography, CMR, HRV, VO2max, and FMD provide comparable or greater diagnostic accuracy without ionizing radiation. I explain which modality is indicated for whom.
Read articleIn public communication, blood pressure is reduced to a single regulator: table salt. In practice, sodium is not the main driver in one third of patients with resistant hypertension. The effect of a low-salt diet on systolic blood pressure is 4–5 mm Hg on average, whereas sleep apnea or chronic stress can add +20 or more. I review six hidden drivers and a holistic protocol.
Read articleThe heart is not only a pump. It is an endocrine organ that synthesizes natriuretic peptides (ANP, BNP, CNP), the body’s own diuretic and vasodilator. NT-proBNP is the most sensitive biomarker of heart failure available in routine laboratories. I review physiology, diagnostic windows, and principles for supporting the peptide factory.
Read articleUp to 30% of myocardial ischemia episodes occur without classic anginal pain, especially in women, people with diabetes for 5+ years, post-infarction patients, and older adults. A standard resting ECG systematically misses painless ischemia. The prognosis in silent ischemia is often worse than in typical angina because diagnosis is delayed. I review the mechanisms, atypical signals, risk groups, and an instrumental assessment protocol.
Read articleCentenarians from the 5 longevity zones — Okinawa, Sardinia, Ikaria, Loma Linda, and Nicoya — live to 100+ not because of one diet or one type of exercise. Their advantage is synchronization across seven axes: sleep, movement, nutrition, stress, lipids, glycemia, and blood pressure. The heart is a resonant organ that reflects the synchrony of all systems. Social isolation is equivalent to 15 cigarettes per day. Liebig's law: the minimum determines the level. I review the seven-pillar protocol — similar to the AHA's Life's Essential 8, but with a restorative logic.
Read articleNaltrexone at 1.5–4.5 mg/day (10 times lower than addiction-medicine dosing) ceases to act primarily as an antagonist and becomes an immunomodulator. Short nocturnal blockade of μ-opioid receptors produces a rebound increase in endogenous endorphins, TLR4 blockade on microglia, and a Th17 / Treg shift toward tolerance. In Hashimoto thyroiditis, LDN is a third-line candidate when TPO antibodies remain elevated despite an adequate L-T4 dose and corrected selenium and vitamin D deficiencies. I review the mechanism, titration protocol, expected time to effect, and settings where LDN should not be used.
Read articleThyroxine (T4) is a prohormone; the active hormonal form is triiodothyronine (T3). The D1/D2 deiodinase enzyme in the liver, kidneys, intestine, and brain is responsible for T4 → T3 conversion. If the enzyme is not properly assembled from selenium, iron, and zinc, the tablet remains in the bloodstream while tissues remain without a signal. Every third patient on an L-thyroxine dose that is adequate by TSH continues to feel unwell: fatigue, dry skin, hair loss, weight gain, brain fog. This is functional hypothyroidism: a state in which TSH is normal, fT4 is normal, but tissue T3 is not. I review four mechanisms of impaired conversion, markers, target ranges, and a holistic restoration protocol.
Read articleEvidence-based nutrition reduces the “heart diet” to 12 foods that appear on the plate every day and act along three axes: lipids, inflammation, and the endothelium. PREDIMED, involving 7447 patients, showed a 30% reduction in cardiovascular events — this is not a fashionable concept, but a reproducible Mediterranean model. I review each food, dose, mechanism, and the md_pereligyn-format protocol.
Read articleMagnesium is a divalent cation involved in 600+ enzymatic reactions, including regulation of myocardial potassium and calcium channels. Subclinical deficiency is common in 50–60% of adults on a Western diet. The bioavailability and tissue selectivity of four popular forms differ radically: taurate for the myocardium, glycinate for sleep and blood pressure, malate for mitochondria, threonate for the brain. I review how to choose the form for the clinical goal.
Read articleCAC score (coronary artery calcium) is a low-dose non-contrast chest CT scan that directly measures coronary artery calcification using the Agatston scale. Unlike LDL and ApoB, which reflect the risk of plaque formation, CAC shows plaque that has already accumulated. Score 0 gives a 10-year myocardial infarction risk below 1%, CAC > 400 means above 25%. This reclassifies patients more accurately than an ASCVD score based on lipids alone.
Read articleLp(a) is an LDL particle with an additional genetically fixed apoprotein, apo(a). Its level is 70–90% heritable and changes very little throughout life. About 20% of the population has a clinically significant elevation (>50 mg/dL or >125 nmol/L). Lp(a) increases myocardial infarction risk 2–3-fold independently of LDL and ApoB and promotes calcification of the aortic valve. A standard lipid panel does not show it.
Read articleLDL cholesterol reflects the mass of cholesterol inside atherogenic particles. ApoB reflects the number of the particles themselves — one apoB-100 per particle. Atheroma is not formed by cholesterol mass, but by particle penetration through the endothelium. Therefore, particle number is a more direct risk marker, and the discordance between “normal” LDL and high ApoB is missed by the standard lipid panel in every second patient with metabolic syndrome or type 2 diabetes.
Read articleObstructive sleep apnea is recurrent collapse of the upper airway with episodes of hypoxia and microarousals. Each episode causes a sympathetic surge, a blood pressure spike, and swings in intrathoracic pressure: an arrhythmogenic cocktail. Up to 50% of patients with atrial fibrillation have undiagnosed OSA, and without correcting it, any rhythm-restoration strategy has only a temporary effect.
Read articleCoffee is neither a “bad habit” nor an unlimited benefit. Regular consumption is associated with a U-shaped risk curve: both zero intake and >6 cups per day are linked to worse cardiovascular outcomes. The optimum is 2–4 cups of filtered coffee in the first half of the day. The effect does not work only through caffeine: chlorogenic acids, trigonelline, melanoidins, and diterpenes affect the endothelium and insulin resistance independently. I discuss the mechanisms, the AFib paradox, effects on blood pressure, and who truly should limit intake.
Read articleHRV (heart rate variability) is the variability of R-R intervals between heartbeats. A healthy heart does not beat like a metronome. Each interval differs by 20–100 ms, and this variability is a direct indicator of autonomic nervous system balance. Low HRV is an independent predictor of cardiovascular mortality, preceding clinical symptoms by years. Each 1 SD decrease in SDNN is associated with a 32% increase in the risk of a first CV event. I review metrics, age norms, how to measure HRV, and a protocol for improving it through training, breathing, sleep, and nutrition.
Read articleThe podocyte is not merely an epithelial cell, but the final molecular filter of the glomerulus, with foot processes covering more than 1 m² per kidney. Loss of podocyte mass precedes a rise in serum creatinine by 5–15 years. This is a unique window for renoprotection, in which reversibility is supported by DAPA-CKD and CREDENCE data. I discuss slit diaphragm architecture, drivers of injury, early markers, and a holistic protocol.
Read articleACR (albumin/creatinine ratio in a morning urine sample) is the most sensitive noninvasive marker of podocyte and glomerular endothelial injury. The test is simple, inexpensive, available in any laboratory, and irrationally ignored in routine practice. Microalbuminuria is detected 5–15 years before creatinine begins to rise. This is an intervention window in which reversibility is evidence-based. I review the normal range, stages, indications for screening, and a protocol for reducing albuminuria.
Read articleThe glomerular endothelium is not "ordinary kidney vessels," but a specialized filter with 70–100 nm fenestrations and a 200–400 nm thick anionic glycocalyx. It is the first structure to fail in diabetes, preceding podocyte injury and the appearance of albuminuria by 5–10 years. This is a unique intervention window in which reversibility is supported by peer-reviewed data. I review the architecture, drivers, biomarkers, and a holistic restoration protocol.
Read articleSerum creatinine is not a pure marker of kidney function, but a balance between the patient’s muscle mass and the filtration capacity of the glomerulus. In women with low muscle mass, older adults, vegetarians, and patients after sarcopenia, normal creatinine can conceal stage 3A CKD. This blind window has been described in peer-reviewed data. I break down the traps of creatinine, cystatin C as an alternative, ACR, and the CKD-EPI 2021 equation.
Read articleA harmless ibuprofen tablet damages the kidney more often than creatinine in a blood test warns you about it. One 10-day course is safe; ten courses per year without eGFR monitoring is a pathway to stage 3 CKD within a decade. I review three mechanisms of damage, safe doses for different NSAIDs, dangerous combinations, and a safe-use protocol.
Read articleOmeprazole prescribed “just in case for gastritis” can, over ten years, quietly turn the kidney into an organ for nephrology screening. Up to 15% of the adult OECD population takes PPI for more than a year, and in half of cases the indication has not been reassessed. An eight-week course is safe; eight years without reassessment is a path to stage 3 CKD without a single obvious symptom.
Read articleThe category of “hepatoprotectors” — Essentiale, Heptral, Carsil, Hofitol — is a commercial phenomenon of the post-Soviet market, not an EASL/AASLD clinical category. Most of these drugs have no randomized controlled trials with hard endpoints. I review what is genuinely evidence-based, what is marketing, and why MASLD starts with lifestyle, not a pill.
Read articleThe liver suffers silently. Pain appears only when the capsule is stretched or fibrosis has progressed to cirrhosis. Blood tests are the only window into this silent process. But a “normal” ALT of 40 U/L is not normal; it is a statistical artifact from populations with an epidemic of MASLD. The true upper limit is 30 in men and 19 in women (Prati 2002). I explain how to read ALT, what to do with a “slightly elevated” value, and when FIB-4 and FibroScan are needed.
Read articleJAMA · March 2026: after recalculation of the Global Burden of Disease using a new model of subclinical lead exposure, lead rose to **8th place among causes of death from ischemic heart disease** — previously 18th. 1.5 million deaths per year, most of them cardiovascular. Pb blocks eNOS and reduces NO bioavailability, increases arterial stiffness, and accelerates atherosclerosis. There is no safe dose of lead. I review the bone depot, exposure sources, markers, and a chelation-support protocol.
Read articleCholestasis and biliary sludge are common but underdiagnosed causes of right upper quadrant heaviness, nausea after fatty foods, dyspepsia, and chronic fatigue. I review the physiology of bile flow, sphincter of Oddi dysfunction, markers (ALP, GGT, direct bilirubin), the evidence base for TUDCA and UDCA (Lindor PMID 19554543), choleretics (artichoke, choline, betaine), and why prolonged fasting thickens bile.
Read articleFerritin is not a marker of “normal iron,” but an acute-phase protein and an early indicator of overload. Elevation above 300 μg/L in men and 200 in women requires investigation: HFE genetics, transferrin saturation, MASLD, inflammation. I discuss the Fenton reaction as a mechanism of iron-induced hepatocyte injury, the phlebotomy protocol for hereditary haemochromatosis, and the nuances of dietary iron.
Read articleThe AST/ALT ratio — the De Ritis index, described in 1957 — is one of the most underestimated laboratory patterns in hepatology. AST/ALT < 1 is the typical MASLD pattern. > 1.5 suggests alcohol-related liver injury, and > 2 combined with GGT suggests acute alcoholic hepatitis. In cirrhosis, the ratio inverts. I explain enzyme physiology, the interpretation pattern, and how to combine it with FIB-4, NFS, and ELF.
Read articleWhen labs show elevated prolactin, women are often sent for pituitary MRI under the assumption of a prolactinoma. But in the vast majority of cases, this is not about a tumor — it is about dysregulation of dopaminergic control. Understanding this changes both diagnostics and treatment approach.
Read articleL-thyroxine + OCPs to a young woman "just in case" — this is not treatment, it is intervention into the endocrine axis without diagnosis. Let us examine how ethinyl estradiol distorts thyroid labs and why the standard "elevated TSH → give thyroxine" approach often contradicts current clinical guidelines.
Read articleIodine is essential raw material for thyroid hormones, but 80% of cases of its inefficacy or harm are not about dose — they are about systemic context. When selenium and iron are missing, iodine does not heal — it fuels inflammation. Here is the five-stage model: from cellular uptake to T4→T3 conversion.
Read articleWhen you aggressively cut calories, fast, and live in stress, the body does not turn on fat burning — it turns on survival mode. First water leaves and it seems to work. Then reverse T3 rises, active T3 falls, mitochondria slow, you feel cold, swollen, foggy. And weight stalls or creeps up. Here is how to escape this trap.
Read articleMedicine calls it an anomaly. But the data says otherwise. 60 documented cases of radical remission — unexpected recovery from chronic and terminal diseases without an explainable medical cause.
Read articleThe obesity pandemic cannot be explained by "eat less, move more" alone. Professor Bruce Blumberg of UC Irvine coined the term "obesogen" and demonstrated that hundreds of chemicals in food, plastics, and personal care products reprogram metabolism toward fat storage — with effects transmitted across generations.
Read articleHelicobacter pylori infects roughly half the global population and remains the leading cause of chronic gastritis, peptic ulcers, and a significant risk factor for stomach cancer. With antibiotic resistance rates climbing past 30-40% in many regions, evidence-based natural protocols are gaining clinical relevance.
Read articleCordyceps supplements have surged in popularity, but wild Himalayan cordyceps and lab-grown varieties are fundamentally different organisms with distinct chemical profiles. Understanding these differences is essential before choosing a supplement.
Read articleGLP-1 receptor agonists like Ozempic have been hailed as miracle weight loss drugs. But behind the dramatic before-and-after photos lie serious risks — from irreversible stomach paralysis to losing muscle instead of fat.
Read articleThe term "adrenal fatigue" dominates integrative medicine discussions, yet it has never been recognized as a legitimate medical diagnosis. The real issue — HPA axis dysregulation — is well-documented in peer-reviewed literature and has measurable biomarkers, distinct phases, and evidence-based treatment protocols.
Read articleGlutathione is a tripeptide present in every cell of the human body and widely considered the master intracellular antioxidant. It participates in all three phases of hepatic detoxification, protects cells from oxidative damage, and is essential for immune function. Why do its levels decline, and what does the science say about restoring them?
Read articleMedicinal mushrooms are among the fastest-growing categories in the nutraceutical industry. But what lies behind the millennia-old tradition: marketing hype or rigorous science? We examine the clinical evidence for Reishi, Lion's Mane, and Cordyceps — from beta-glucans and immune modulation to neurogenesis and cognitive enhancement.
Read articleAfter age 40, testosterone declines by 1-2% annually. But age-related decline is not always benign. We examine when TRT is genuinely warranted, which labs are essential, and how to optimize testosterone naturally before committing to lifelong therapy.
Read articleMenopause affects every woman. But hot flashes, insomnia, anxiety, and bone loss are not inevitable. We examine the difference between bioidentical and synthetic hormone therapy, reinterpret the WHI study, and outline a personalized approach to menopausal hormone therapy.
Read articleIn 70% of women with PCOS, the root cause is insulin resistance, not a hormonal imbalance. Standard birth control prescriptions mask symptoms without addressing the underlying mechanism. We examine the pathophysiology, proper diagnosis, and a comprehensive treatment protocol.
Read articleMigraine is not "just a headache." It is a neurovascular disease affecting 12% of the population. Standard painkiller treatment leads to medication-overuse headache. We examine accurate diagnosis, the CGRP pathway, and an evidence-based prevention protocol.
Read articleThe nootropics market is valued at $6 billion and growing at 15% annually. But which of the hundreds of "smart drugs" are actually supported by clinical evidence? We examine citicoline, Lion's Mane, racetams, and modafinil — from mechanisms to protocols.
Read articleChronic insomnia affects 10-15% of adults and is associated with increased risk of cardiovascular disease, type 2 diabetes, and dementia. We examine the evidence-based sleep restoration formula: GABA, glycine, magnesium, L-theanine, and melatonin.
Read articleNAD+ (nicotinamide adenine dinucleotide) is a central coenzyme of energy metabolism whose levels decline by roughly 50% by age 50. We examine the science behind the hype: sirtuins, NMN vs NR, IV NAD+, epigenetic clocks, and real-world protocols.
Read articleTotal cholesterol and standard LDL are outdated cardiovascular risk markers. LDL particle size, particle count (LDL-P), and ApoB/ApoA1 ratio tell a fundamentally different story. We examine when statins truly are not needed and what works instead.
Read articleStandard multivitamins contain nutrients in forms and dosages that ignore individual genetics, microbiome, and current deficiency status. We examine the personalized nutraceutical approach — from blood tests to custom-compounded capsules.
Read articleIncreased intestinal permeability — commonly known as leaky gut — is no longer a fringe concept. Peer-reviewed research now places it at the center of autoimmune, metabolic, and neuroinflammatory disease. We examine the evidence and restoration protocols.
Read articlePregnenolone — the precursor to every steroid hormone in the body — occupies a unique position at the intersection of endocrinology and neuroscience. During chronic stress and burnout, its levels decline among the first, triggering a cascade of hormonal disruption.
Read articleContinuous glucose monitoring (CGM) has revolutionized diabetes management by providing real-time data instead of isolated fingerstick readings. We review the latest sensors, key metrics, and practical use cases.
Read articleLithium at therapeutic doses has long been used for bipolar disorder. But microdoses of lithium (5-20 mg elemental) demonstrate remarkable neuroprotective and anxiolytic effects without the side effects of high-dose therapy.
Read articleCannabidiol (CBD) — the non-psychoactive phytocannabinoid from Cannabis sativa — has become one of the most researched molecules in neuropharmacology. We review the evidence base for chronic pain, anxiety, and neuroinflammatory conditions.
Read articleYour doctor measures fasting glucose and HbA1c but never orders fasting insulin or calculates HOMA-IR. That's like checking temperature during pneumonia without doing a chest X-ray. Here's why this simple index is the key to early diagnosis.
Read articleShe was 54, had lived with diabetes for 11 years, and was on four medications. They told her the disease was progressive. Five months later, her HbA1c was 5.4% — with zero medications.
Read articleLabs are normal but symptoms persist? 15-20% of patients on levothyroxine continue to suffer from fatigue, weight gain, and brain fog. The problem isn't the patient — it's the approach.
Read article"Can type 2 diabetes be cured?" — millions of people ask this question worldwide. Conventional medicine says no, only managed. But clinical research and practice tell a different story.
Read articleHigh blood sugar is a symptom, not the cause. The real problem is insulin resistance. While you fight symptoms, the disease progresses.
Read articleYou're dieting, counting calories, but the weight won't budge. With type 2 diabetes, this is typical. The reason isn't a lack of willpower — it's a hormonal block.
Read articleBerberine has been called "nature's metformin" — but how does it actually compare? As a physician who has used both in clinical practice, here's what the evidence shows.
Read articlePrediabetes affects 96 million Americans — one in three adults. The good news? It's the most reversible stage of metabolic dysfunction, with 95%+ success rates when caught early.
Read articleNot all supplements are created equal. After treating 500+ patients for insulin resistance, these are the 7 compounds backed by both research and clinical results.
Read article
